More IVD Mergers: Qiagen Offers To Buy Exiqon; DiaSorin Buys Focus From Quest; Thermo Finishes Affymetrix Deal
This article was originally published in Clinica
The in-vitro diagnostics industry continues to be a hot area for merger and acquisition activity, with three significant deals announced at the end of March.
You may also be interested in...
Diagnostics, orthopedics, and cardiovascular device companies are among those that wait until November to report their results for the quarter that ended at the end of September. Medtech Insight’s Earnings Winners & Losers highlights some of the companies that had news to celebrate, and a few that were disappointed with the quarter.
The company’s leadership discussed its recent investments in robotic surgery technology during Johnson & Johnson’s 2019 fourth-quarter earnings call on 22 January. The company will provide more information on its robotic surgery platforms at its investors meeting in May in New York.
Three-month results from a 94-patient randomized trial of Medtronic’s Intellis spinal cord stimulation system showed superior back-pain relief with the differential target multiplexed waveform compared to conventional spinal cord stimulation.